Filing Details
Neuronetics, Inc. (NASDAQ:STIM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 04, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:STIM
Neuronetics, Inc. (STIM) Files Quarterly Report for Q0
Neuronetics, Inc. (NASDAQ:STIM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 04, 2026.
At publication ·
What changed
Neuronetics, Inc. (NASDAQ:STIM) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Neuronetics, Inc. (NASDAQ: STIM) filed its quarterly 10-Q report with the SEC on November 4, 2026.
- The healthcare company's stock trades at $2.26 per share with a market capitalization of $94.2 million.
- The quarterly report includes unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
Neuronetics, Inc.'s stock currently trades at $2.26 with a market capitalization of $94.2M.
The 10-Q provides Neuronetics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Neuronetics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View STIM Stock Page
Frequently Asked Questions
Where can I read STIM's SEC filings?
Browse all filings on our STIM SEC filings page.
What types of SEC filings does Neuronetics, Inc. file?
Public companies like Neuronetics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.